数据显示，仅8月份胖东来就实现销售额19.84亿元，平均每天进账约6323.96万元。其中，超市、珠宝、 百货、电器、服装五大主力业态表现突出，单月销售额全部超过亿元。 从累计数据来看，前8个月超市业态以超过84亿元的销售额稳居核心地位，占总收入的54.72%，而珠 宝、百货、电器和服饰四大板块也都突破了10亿元大关。 日前，零售巨头胖东来公布最新经营数据显示，今年1至8月累计销售额突破153.68亿元，展现出强劲的 增长势头。凭借这一亮眼业绩，这家被誉为"零售业神话"的企业今年全年销售额超越去年近170亿元的 成绩已无悬念，更有望突破200亿元大关。 随着新乡三胖店和计划中的郑州首店陆续开业，胖东来在河南零售市场的领先地位将进一步巩固。这个 从许昌起步的零售企业，正用自己的方式书写着中国零售业的传奇。 为维护品牌声誉，胖东来于9月1日发布声明，宣布设立打击假冒自有品牌商品的专项奖励机制，对提供 有效线索的举报者给予最高500万元的现金奖励。 胖东来目前在许昌和新乡两地共拥有14家门店，其中8月份有6家门店销售额超过亿元。时代广场店以 5.26亿元的单月销售额持续领跑，天使城店、大胖店和小胖店也以超过2亿元的 ...

知名连锁超市永辉超市（601993.SH）在2025年上半年遭遇业绩滑坡后，不得不调整其大规模门店改造 计划。 日前，永辉超市发布公告称，拟将募集资金用于调改的门店数量从原计划的298家减少至216家，募集资 金总额也从不超过约39.92亿元调整为不超过约31.14亿元。 永辉超市2025年上半年的经营状况确实不容乐观。财报数据显示，永辉超市上半年实现营业收入299.48 亿元，同比下降20.73%；归属于上市公司股东的净亏损达到2.41亿元，与去年同期盈利2.75亿元相比， 同比亏损增加5.16亿元。 收入下滑的主要原因与永辉超市2024年下半年开启的整体战略与经营深度转型密切相关。为了扭转经营 困境，永辉不得不关闭长期亏损的门店，并让部分门店在调改期歇业。虽然经过调改的门店收入较同期 有大幅度增加，但这些增长远远无法弥补因关店而产生的收入下降。截至2025年6月底，永辉在全国的 534家门店中，已完成调改的仅有124家，占比约23%。 利润亏损的原因有多个方面。除了整体销售规模减少外，永辉超市进行的商品供应链改革也带来了短期 阵痛。报告期内，永辉超市完成了大量供应商及商品的升级汰换，这导致短期内承受一定的 ...

此次交接正值华润啤酒业绩表现亮眼之际。华润啤酒2025年中期财报显示，上半年实现净利润57.89亿 元，同比增长23%，创下历史新高。但华润啤酒同时也面临着啤酒高端化竞争加剧和白酒业务整合的双 重挑战。上半年白酒业务营业额同比下降超三成，与啤酒业务的稳健增长形成鲜明对比。 赵春武的职业轨迹与前任主席侯孝海颇为相似。他于2022年5月被任命为公司副总裁，次年8月升任执行 董事兼总裁。据华润啤酒公告，截至2024年12月31日止年度，赵春武的薪酬包括18万元董事袍金、约 158.52万元的薪金及津贴，以及约178.78万元的酌情花红。 华润啤酒董事会对赵春武给予高度评价，认为他在担任执行董事及总裁期间展现出卓越的管理和领导能 力。董事会基于其工作经验、全面领导能力和卓越工作表现，认为他是主席职务的最佳人选，并相信他 能够推动公司及其附属公司实现进一步发展。 华润啤酒（00291.HK）于9月3日正式宣布，执行董事赵春武由总裁调任为董事会主席，并担任公司财 务委员会主席。这一人事变动标志着华润啤酒在创始人侯孝海离职两个月后，终于迎来了新的掌舵者。 今年54岁的赵春武是华润啤酒体系内成长起来的高级管理人员。他于200 ...

公开资料显示，长进光子实控人兼董事长为李进延，1972年出生，拥有博士研究生学历。2001年8月至2005年6月，任烽火通信高级研发工程师；2005年7月 至2008年10月，任烽火藤仓光纤研发部经理；2008年11月至今，任武汉光电国家研究中心教授、博士生导师，并于2025年7月办理离岗创业。 近日，武汉长进光子技术股份有限公司（以下简称"长进光子"）科创板上市申请获上交所受理。该公司此次IPO拟募资7.80亿元，计划用于高性能特种光纤 生产基地及研发中心项目、补充流动资金。 来源：公告 长进光子成立于2012年，主要从事特种光纤的研发、生产及销售，主要产品掺稀土光纤通过内置于各类光纤激光器、光纤放大器、光纤激光雷达，应用于先 进制造、光通信、测量传感、国防军工等领域。 招股书显示，2022年至2024年，长进光子营业收入从2022年的1.08亿元增长至2024年的1.92亿元，净利润从0.37亿元增长至0.76亿元，毛利率分别达 66.37%、69.31%、69.13%。 GPLP犀牛财经注意到，2012年至2025年3月，长进光子共计完成6轮融资，投后估值从2亿元飙升至18亿元，投资阵容包括杰普特、哈勃 ...

Core Viewpoint - Changsha Bank's 2025 semi-annual report indicates a steady growth in total assets and liabilities, but faces challenges in profitability and asset quality due to narrowing net interest margins and rising non-performing loans [2][3]. Financial Performance - As of June 30, 2025, total assets reached 1,247.385 billion RMB, a year-on-year increase of 13.72% - Total liabilities amounted to 1,165.090 billion RMB, up 13.58% year-on-year - Total loans stood at 602.692 billion RMB, reflecting a 12.95% increase year-on-year - Total deposits were 759.184 billion RMB, growing by 11.23% year-on-year - For the first half of 2025, operating income was 13.249 billion RMB, a 1.59% increase year-on-year - Net profit reached 4.329 billion RMB, up 5.05% year-on-year [2][4]. Asset Quality - As of June 30, 2025, non-performing loan balance was 7.046 billion RMB, an increase of 0.662 billion RMB from the end of the previous year - Non-performing loan ratio remained stable at 1.17%, with a slight decrease of 1 basis point from the previous quarter - Personal loan non-performing ratio increased significantly to 2.20%, up 33 basis points from the end of the previous year - Overdue loan balance was 13.405 billion RMB, a substantial increase of 36.02% from the end of the previous year [3][6]. Capital Adequacy - Capital adequacy ratios for Changsha Bank showed a slight decline compared to the end of the previous year, but remained compliant with regulatory standards [3]. Institutional Shareholding - As of June 30, 2025, the proportion of institutional shareholders who increased or newly entered their holdings rose by 0.82%, while those who reduced or exited their holdings decreased by 1.90%, resulting in a net reduction of 1.18% in institutional shareholding [6]. Market Challenges - The bank faces challenges in expanding personal loans and corporate deposits due to a slow growth rate in housing mortgage loans and adjustments in deposit structure - There is an increasing pressure on credit risk management as overdue and attention-class loans have risen [6].

近日，厦门优迅芯片股份有限公司（以下简称"优迅股份"）回复了上交所首轮审核问询函，涉及问题产品和技术、市场空间、控制权、业绩波动、募投项目 等11个问题。 优迅股份此次科创板IPO拟募资8.89亿元，计划用于下一代接入网及高速数据中心电芯片开发及产业化项目、车载电芯片研发及产业化项目、800G及以上光 通信电芯片与硅光组件研发项目、补充流动资金。 优迅股份成立于2003年2月，主要从事光通信前端收发电芯片的研发、设计与销售，产品主要应用于光模组（包括光收发组件、光模块和光终端）中，应用 场景涵盖接入网、4G/5G/5G-A无线网络、数据中心、城域网和骨干网等领域。 招股书显示，优迅股份的创始人为Ping Xu、柯炳粦、张为农、张小闽、吴晞敏。其中实控人兼总经理Ping Xu以技术入股，持股比例60%，其余人均以货币 方式出资。 2007年至2022年，因优迅股份技术产品开发、盈利情况不及预期，Ping Xu与股东、经营层之间分歧、纠纷持续升级。期间，Ping Xu反对"股权转让""对员工 股权激励并设立员工持股平台股权""聘任柯炳粦兼任总经理""聘任财务总监"等多项议案，优迅股份则以Ping Xu"另起炉灶" ...

Core Viewpoint - Wuxi Xihua Technology Co., Ltd. has received approval for its IPO after nearly two years of waiting, but concerns have arisen due to the company's second change in fundraising purposes [2] Company Overview - Established in 2001, Xihua Technology specializes in the R&D, manufacturing, and sales of components for wind turbine gearboxes, primarily serving large wind power equipment and injection molding machine sectors. It is one of the few companies in China that can provide full-process services for wind turbine gearbox components [4] IPO Fundraising Plans - The company initially planned to raise 2.048 billion yuan for projects related to the industrialization of core wind power equipment, the construction of a research and development center, and to supplement working capital [4] - Following the review inquiry phase, the company adjusted its fundraising amount for the "supplementing working capital" project from 550 million yuan to 200 million yuan, and later canceled this project, reducing the total fundraising amount to 1.498 billion yuan [6] Financial Performance - In the first half of 2025, Xihua Technology reported revenue of 580 million yuan, a year-on-year increase of 36.67%, and a net profit of 142 million yuan, up 52.99% year-on-year [5] - From 2022 to 2024, the company's revenue showed fluctuations with year-on-year changes of 7.29%, -3.62%, and 5.19%, while net profit experienced declines of 14.61%, 4.25%, and 19.65%, indicating significant volatility and instability in performance [5] - The net profit margin has decreased from 25.47% in 2020 to 14.87% in 2024, marking a continuous decline over five years [5] - In 2022, prior to the IPO application, the company issued a substantial cash dividend of 350 million yuan, leading to a 46.19% drop in retained earnings compared to the end of 2021 [5]

Group 1 - The acquisition plan of Mengwang Cloud Technology Group Co., Ltd. for Hangzhou Bicheng Digital Technology Co., Ltd. has been officially terminated due to a legal obstacle caused by the freezing of 10.51 million shares held by the third-largest shareholder, Hangzhou Chengxiang Enterprise Management Partnership [2] - The failed acquisition signifies another setback for Bicheng Digital's path to capitalization, as the company had previously submitted an IPO application in December 2021 to raise 788 million yuan but withdrew it eight months later due to regulatory concerns [5] - Bicheng Digital operates as a comprehensive e-commerce service provider, covering brand retail, operational management, channel distribution, and digital marketing, with notable clients including Siemens, BMW, and Omron [5] Group 2 - The entity Hangzhou Chengxiang, which became the third-largest shareholder of Bicheng Digital in May 2023, is now embroiled in a contractual dispute leading to the freezing of its shares, highlighting ongoing uncertainties at the shareholder level [5]

8月31日，甫康生物科技（上海）股份有限公司（以下简称"甫康药业"）正式向港交所主板递交上市申请，农银国际、民银资本及复星国际资本担任联席保 荐人。 据港交所披露的文件，甫康药业成立于2015年11月，专注于开发癌症相关疾病治疗领域疗法，同时兼顾针对病毒和衰老疾病领域创新药物的开发及商业化。 财务数据显示，甫康药业至今尚未实现盈利。2023-2024年及2025年上半年，甫康药业营业收入分别为0元、1782.5万元和3467.5万元，净亏损分别为9465.5 万元、7452.5万元和3593.4万元。两年半时间内，甫康药业累计亏损已经达到2.05亿元。当前，甫康药业收入几乎全部依赖2024年6月商业化的首款产品"汉 奈佳"（马来酸奈拉替尼片），这是一种用于治疗HER2阳性乳腺癌的药物。 截至2025年6月末，甫康药业现金及现金等价物为1.618亿元，管理层估计这些资金可维持15个月运营。 值得注意的是，在此次IPO过程中，甫康药业还遭遇两起诉讼。2025年1月21日，武汉伯瑞恒医药科技有限公司起诉甫康药业、实控人沈孝坤及其配偶黄素 玲，要求赔偿未付研究费19.9万元及利息。另一家武汉普渡生物医药有限公司则起诉 ...

Core Viewpoint - Fujian Wancheng Biotechnology Group Co., Ltd. is attempting to overcome growth bottlenecks in its bulk snack business through a series of capital operations, including a significant acquisition and plans for an IPO in Hong Kong, amidst intense industry competition and rising debt levels [2][4]. Group 1: Acquisition and Financial Moves - The company plans to acquire 49% of Nanjing Wanyou Commercial Management Co., Ltd. for 1.379 billion yuan [3]. - This acquisition is expected to further increase the company's debt ratio to approximately 90%, significantly raising short-term repayment pressures [6]. - The board has approved the plan for an IPO in Hong Kong, aiming to enhance international strategy, brand recognition, and supply chain systems [3][4]. Group 2: Industry Competition and Market Dynamics - The domestic bulk snack market is projected to exceed 100 billion yuan in 2024, with over 40,000 stores, leading to intensified competition and price wars [4]. - Competitors like Mingming Hen Mang are employing aggressive strategies, including zero franchise fees and substantial subsidies to counteract Wancheng's market presence [4]. - Wancheng's brands, such as "Hao Xiang Lai," are responding with similar tactics, indicating a highly competitive environment [4]. Group 3: Financial Performance and Challenges - Wancheng's gross margin has fluctuated significantly, dropping from 14.40% in 2022 to 9.52% in 2023, before slightly recovering to 10.86% in 2024 [5]. - The company's rapid expansion through acquisitions has led to a debt ratio of 68.95% as of mid-2025, raising concerns about its short-term liquidity [5]. - The recent leadership change, with the founder stepping down amid regulatory scrutiny, may be aimed at stabilizing governance ahead of the IPO [6].